Personalized Cell Therapies Cellino specializes in personalized cell therapies derived from induced pluripotent stem cells (iPSCs) for chronic degenerative diseases, offering a unique solution in the biotechnology research industry.
Recent Expansions Recent expansions in key personnel appointments, such as Chris Gibson to the Board of Directors and Ed Tekeian as Senior Vice President of Engineering, indicate growth opportunities and potential collaborative avenues for sales partnerships.
Government Funding Receiving funding from the US government and a $25 million grant from ARPA-H positions Cellino strongly for further technological advancements and product development, creating opportunities for strategic sales initiatives.
Strategic Investments Significant investments from firms like Leaps by Bayer and venture capital funding totaling $96 million showcase investor confidence in Cellino's innovative approach, presenting opportunities for sales growth and industry collaboration.
Competitive Positioning With a revenue range of $10-50 million, Cellino stands out among similar biotechnology companies, offering sales representatives a competitive edge in promoting cutting-edge biomanufacturing solutions to potential clients.
487
$50M$100M
501$100M$1B
501$100M$1B
11K$1B
51$10M$50M
2.1K$100M$1B
91Cellino uses 8 technology products and services including MySQL, Shopify, Font Awesome, and more. Explore Cellino's tech stack below.
| Cellino Email Formats | Percentage |
| FLast@cellinobio.com | 50% |
| FLast@cellinobio.com | 50% |
Biotechnology ResearchMassachusetts, United States51-200 Employees
Cellino is building a scalable, automated biomanufacturing system for potentially curative personalized cell therapies. Cellino’s vision is to enable healthier lives worldwide with personalized treatments derived from induced pluripotent stem cells (iPSCs), which can serve as the basis for therapies for a host of chronic degenerative diseases, including vision loss and Parkinson's disease.
Company Overview
Media & News
Funding & FinancialsCellino has raised a total of $25M of funding over 6 rounds. Their latest funding round was raised on Sep 10, 2024 in the amount of $25M.
Cellino's revenue is in the range of $10M$50M
Funding & FinancialsCellino has raised a total of $25M of funding over 6 rounds. Their latest funding round was raised on Sep 10, 2024 in the amount of $25M.
Cellino's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com